Jessica Bridoux

Jessica Bridoux is a Researcher at the Department of Molecular Imaging and Therapy, Vrije Universiteit Brussel (VUB). She holds an external employee role supporting clinical sciences and is actively involved in postdoctoral research. Her work focuses on developing radiopharmaceuticals using single-domain antibodies for PET imaging and theranostic applications.

Research Interests: Her research integrates bioconjugation strategies, automated radiochemistry, and immuno-PET tracers targeting immune checkpoints (e.g., PD-L1, TIGIT) for cancer diagnostics. She collaborates on projects like the GEAR TOPGUN platform and VYPER, advancing enzyme-mediated bioconjugation technologies.

Key Contributions: Bridoux has pioneered automated radiofluorination methods and optimized nanobody-based tracers for clinical translation. Her work bridges preclinical and clinical PET applications, emphasizing precision oncology and personalized treatment screening.

• Grants/Projects: 10+ funded projects (2016–2028), including FWO and SRP grants
• Labs/Teams: Active in the Exploit-PeptIT research center and collaborates internationally on theranostic development